AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Oncology Research Article
PDF (104 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Retraction | Open Access

Retraction: MYBL2 is targeted by miR-143-3p and regulates breast cancer cell proliferation and apoptosis

Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Oncology Research
Volume 33 Issue 3,
February 2025
Pages 739-739
DOI: 10.32604/or.2024.056911

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Retraction: MYBL2 is targeted by miR-143-3p and regulates breast cancer cell proliferation and apoptosis. Oncology Research, 2025, 33(3): 739. https://doi.org/10.32604/or.2024.056911

259

Views

20

Downloads

0

Crossref

0

Web of Science

0

Scopus
Published: 28 February 2025
© The Author 2024.

This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.